Catalyst Wire Dossier Catalyst Wire Dossier

Reltecimod

Reltecimod · Atox Bio Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Reltecimod, covering 2021-09-16 to 2021-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury [Phase 3]

See pricing